BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24481757)

  • 21. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
    Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
    J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging.
    Schaarschmidt BM; Sawicki LM; Gomez B; Grueneisen J; Hoiczyk M; Heusch P; Buchbender C
    Clin Imaging; 2016; 40(5):956-60. PubMed ID: 27232931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deciduoid pleural mesothelioma in an adolescent.
    Arango-Tomás E; Algar-Algar FJ; Salvatierra Velázquez A
    Arch Bronconeumol; 2013 May; 49(5):218-9. PubMed ID: 23265622
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.
    Cardinale L; Ardissone F; Gned D; Sverzellati N; Piacibello E; Veltri A
    Acta Biomed; 2017 Aug; 88(2):134-142. PubMed ID: 28845826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pulmonary and mediastinal masses.
    Newell JD
    Med Clin North Am; 1984 Nov; 68(6):1463-80. PubMed ID: 6392773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
    Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D
    Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRT, CT and sonography in the preoperative assessment of the primary tumor spread in malignant pleural mesothelioma].
    Layer G; Schmitteckert H; Steudel A; Tuengerthal S; Schirren J; van Kaick G; Schild HH
    Rofo; 1999 Apr; 170(4):365-70. PubMed ID: 10341795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET-CT: current applications and new developments in the thorax.
    Erasmus JJ; Mawlawi O; Howard B; Patz EF
    Semin Respir Crit Care Med; 2014 Feb; 35(1):145-56. PubMed ID: 24481767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging the solitary pulmonary nodule.
    Alpert JB; Lowry CM; Ko JP
    Clin Chest Med; 2015 Jun; 36(2):161-78, vii. PubMed ID: 26024598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic contrast-enhanced CT and MRI for pulmonary nodule assessment.
    Ohno Y; Nishio M; Koyama H; Miura S; Yoshikawa T; Matsumoto S; Sugimura K
    AJR Am J Roentgenol; 2014 Mar; 202(3):515-29. PubMed ID: 24555587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response evaluation in mesothelioma: Beyond RECIST.
    Cheng L; Tunariu N; Collins DJ; Blackledge MD; Riddell AM; Leach MO; Popat S; Koh DM
    Lung Cancer; 2015 Dec; 90(3):433-41. PubMed ID: 26443279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
    Paul NS; Ley S; Metser U
    Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.
    Truong MT; Marom EM; Erasmus JJ
    J Thorac Imaging; 2006 May; 21(2):146-53. PubMed ID: 16770231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of pleural and chest wall tumors.
    Weyant MJ; Flores RM
    Thorac Surg Clin; 2004 Feb; 14(1):15-23. PubMed ID: 15382305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of imaging in malignant pleural mesothelioma.
    Marom EM; Erasmus JJ; Pass HI; Patz EF
    Semin Oncol; 2002 Feb; 29(1):26-35. PubMed ID: 11836666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical assessment of pleural thickening].
    Downer NJ; Ali NJ; Au-Yong IT
    Praxis (Bern 1994); 2013 Jun; 102(12):741-5. PubMed ID: 23735766
    [No Abstract]   [Full Text] [Related]  

  • 38. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.
    Armato SG; Coolen J; Nowak AK; Robinson C; Gill RR; Straus C; Khanwalkar A
    Lung Cancer; 2015 Nov; 90(2):148-54. PubMed ID: 26298162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma.
    Eibel R; Tuengerthal S; Schoenberg SO
    Curr Opin Oncol; 2003 Mar; 15(2):131-8. PubMed ID: 12601277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.